Partial Substitution of Glucose with Xylitol Suppressed the Glycolysis and Selectively Inhibited the Proliferation of Oral Cancer Cells

References

• Hanahan D, and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144 (5), 646–674, 2011.
   PubMed Web of Science ®Google Scholar
• Aziz NM: Cancer survivorship research: challenge and opportunity. J Nutr 132 (11 Suppl), 3494S–3503S, 2002.
   PubMed Web of Science ®Google Scholar
• Sierpina V, Levine L, McKee J, Campbell C, Lian S, et al.: Nutrition, metabolism, and integrative approaches in cancer survivors. Semin Oncol Nurs 31 (1), 42–52, 2015.
   PubMed Web of Science ®Google Scholar
• De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, et al.: Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutat Res 480–481, 9–22, 2001.
   PubMed Web of Science ®Google Scholar
• Ortega AD, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, et al.: Glucose avidity of carcinomas. Cancer Lett 276 (2), 125–135, 2009.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, and Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324 (5930), 1029–1033, 2009.
   PubMed Web of Science ®Google Scholar
• Lunt SY, and Vander Heiden MG: Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 27, 441–464, 2011.
   PubMed Web of Science ®Google Scholar
• Froesch EraJ A: The metabolism of xylitol. Sugars in nutrition. Academic Press; 1974.
   Google Scholar
• Wang YM, and van Eys J: Nutritional significance of fructose and sugar alcohols. Annu Rev Nutr 1, 437–475, 1981.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association: Standards of Medical Care in Diabetes – 2010. Diabetes Care 33 (Suppl 1), S11–S61, 2010.
   PubMed Web of Science ®Google Scholar
• Twetman S: Consistent evidence to support the use of xylitol- and sorbitol-containing chewing gum to prevent dental caries. Evid Based Dent 10 (1), 10–11, 2009.
   PubMedGoogle Scholar
• Nayak PA, Nayak UA, and Khandelwal V: The effect of xylitol on dental caries and oral flora. Clin Cosmet Investig Dent 6, 89–94, 2014.
   PubMedGoogle Scholar
• Miyasawa H, Iwami Y, Mayanagi H, and Takahashi N: Xylitol inhibition of anaerobic acid production by Streptococcus mutans at various pH levels. Oral Microbiol Immunol 18 (4), 215–219, 2003.
   PubMedGoogle Scholar
• Hammoudi N, Ahmed KB, Garcia-Prieto C, and Huang P: Metabolic alterations in cancer cells and therapeutic implications. Chin J Cancer 30 (8), 508–525, 2011.
   PubMedGoogle Scholar
• Sato J, Wang YM, and van Eys J: Metabolism of xylitol and glucose in rats bearing hepatocellular. Cancer Res 41 (8), 3192–3199, 1981.
   PubMed Web of Science ®Google Scholar
• Choi S, and Myers JN: Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87 (1), 14–32, 2008.
   PubMed Web of Science ®Google Scholar
• Hayward MC, and Shea AM: Nutritional needs of patients with malignancies of the head and neck. Semin Oncol Nurs 25, 203–211, 2009.
   PubMedGoogle Scholar
• Van den Berg MG, Rütten H, Rasmussen-Conrad EL, Knuijt S, Takes RP, et al.: Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional study. Head Neck 36 (1), 60–65, 2014.
   PubMed Web of Science ®Google Scholar
• Chainani-Wu N, Epstein J, and Touger-Decker R: Diet and prevention of oral cancer: strategies for clinical practice. J Am Dent Assoc 142 (2), 166–169, 2011.
   PubMed Web of Science ®Google Scholar
• Pereira KM, Chaves FN, Viana TS, Carvalho FS, Costa FW, et al.: Oxygen metabolism in oral cancer: HIF and GLUTs (Review). Oncol Lett 6 (2), 311–316, 2013.
   PubMed Web of Science ®Google Scholar
• Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, et al.: Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer 117 (13), 2926–2938, 2011.
   PubMed Web of Science ®Google Scholar
• Sano D, Xie T, Ow TJ, Zhao M, Pickering CR, et al.: Disruptive TP53 Mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res 17 (21); 6658–6670, 2011.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Chen G, Zhang W, Lu W, Zhang H, et al.: Loss of p53 in stromal fibroblasts promotes epithelial cell invasion through redox-mediated ICAM1 signal. Free Radic Biol Med 58, 1–13, 2013.
   PubMed Web of Science ®Google Scholar
• Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, et al.: Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20, 1436–1447, 2000.
   PubMed Web of Science ®Google Scholar
• Czekanska EM: Assessment of cell proliferation with resazurin-based fluorescent dye. Methods Mol Biol 740, 27–32, 2011.
   PubMedGoogle Scholar
• Mosmann T.: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55–63, 1983.
   PubMed Web of Science ®Google Scholar
• Crouch SP, Kozlowski R, Slater KJ, and Fletcher J: The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160 (1), 81–88, 1993.
   PubMed Web of Science ®Google Scholar
• Shlmojo N, Naka K, NakajIma C, Yoshikawa C, and Okuda K: Test-Strip Method for Measuring Lactate in Whole Blood. Clin Chem 35 (9), 1992–1994, 1989.
   PubMed Web of Science ®Google Scholar
• Li S, Wu L, Feng J, Li J, Liu T, et al.: In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity. Sci Rep 28; 6, 28479, 2016.
   Web of Science ®Google Scholar
• Pelicano H, Martin DS, Xu RH, and Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 25, 4633–4646, 2006.
   PubMed Web of Science ®Google Scholar
• Kohler LN, Garcia DO, Harris RB, Oren E2, Roe DJ, et al.: Adherence to diet and physical activity cancer prevention guidelines and cancer outcomes: a systematic review. Cancer Epidemiol Biomarkers Prev 25 (7), 1018–1028, 2016.
   PubMed Web of Science ®Google Scholar
• Fergusona LR, Chenb H, Collins AR, Connell M, Damia G, et al.: Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol 35, S5–S24, 2015.
   PubMed Web of Science ®Google Scholar
• Ames BN: DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mut Res 475, 7–20, 2001.
   PubMed Web of Science ®Google Scholar
• Park E, Park MH, Na HS, and Chung J: Xylitol induces cell death in lung cancer A549 cells by autophagy. Biotechnol Lett 37, 983–990, 2015.
   PubMed Web of Science ®Google Scholar
• Yalcin A, Telang S, Clem B, and Chesney J: Joint FAO/WHO Food Standards Programme. Codex alimentarius commission twenty-first session, 1995: WHO Food Additives Series No. 12.
   Google Scholar
• Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, et al.: Association of cancer metabolism-related proteins with oral carcinogenesis – indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? J Transl Med 12, 208, 2014.
   PubMed Web of Science ®Google Scholar
• Mor I, Cheung EC, and Vousden KH: Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb Symp Quant Biol 76, 211–216, 2011.
   PubMedGoogle Scholar
• Yalcin A, Telang S, Clem B, and Chesney J: Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatases in cancer. Exp Mol Pathol 86 (3), 174–179, 2009.
   PubMed Web of Science ®Google Scholar
• Wang G, Xu Z, Wang C, Yao F, Li J, et al.: Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues. Oncol Lett 6 (6), 1701–1706, 2013.
   PubMed Web of Science ®Google Scholar
• Ros S, and Schulze A: Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2, 6-bisphosphatases in cancer metabolism. Cancer Metab 1 (1), 8, 2013.
   PubMedGoogle Scholar
• Viale A, Corti D, and Draetta GF: Tumors and mitochondrial respiration: a neglected connection. Cancer Res 75 (18), 3685–3686, 2015.
   PubMed Web of Science ®Google Scholar
• Rosen DG, Yang G, Bast RC Jr, and Liu J: Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer. Methods Enzymol 407, 660–676, 2006.
   PubMed Web of Science ®Google Scholar
• Yaacoub K, Pedeux R, Tarte K, and Guillaudeux T: Role of the tumor microenvironment in regulating apoptosis and cancer progression. Cancer Lett 378 (2), 150–159, 2016.
   PubMed Web of Science ®Google Scholar
• Ur-Rehman S, Mushtaq Z, Zahoor T, Jamil A, and Murtaza MA: Xylitol: a review on bioproduction, application, health benefits, and related safety issues. Crit Rev Food Sci Nutr 55 (11), 1514–1528, 2015.
   PubMed Web of Science ®Google Scholar
• PDQ Supportive and Palliative Care Editorial Board: Gastrointestinal Complications (PDQ®): Health Professional Version. PDQ Cancer Information summaries, National Cancer Institute (US); 2002–2015.
   Google Scholar
• Tennant DR: Potential intakes of total polyols based on UK usage survey data. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31 (4), 574–586, 2014.
   PubMed Web of Science ®Google Scholar